BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion

Area of Science:

• Endocrinology
• Metabolic Diseases
• Public Health

Background:

• Diabetes mellitus is a growing global health crisis, with Type 2 diabetes mellitus (T2DM) being a major cause of mortality.
• Uncontrolled T2DM is prevalent, particularly in India, where 70% of diagnosed cases lack adequate glycemic control.
• Current guidelines recommend early insulin initiation for T2DM patients with HbA1c > 10% when oral agents are insufficient.

Purpose of the Study:

• To provide an expert opinion on the timely and appropriate use of basal insulin in T2DM management.
• To address challenges and misconceptions associated with insulin initiation and titration.
• To emphasize the benefits of early glycemic control in preventing diabetes complications.

Main Methods:

• Formulation of an expert panel opinion based on existing guidelines and clinical experience.
• Consideration of economic and cultural contexts relevant to diabetes management in India.
• Focus on the seven vital Ts for effective insulin therapy: treatment initiation, timing, transportation/storage, technique, titration targets, tablets, and monitoring tools.

Main Results:

• Early insulin initiation and optimization of glycemic control can effectively manage uncontrolled T2DM.
• Patient empowerment and structured insulin titration algorithms are key to successful management.
• Timely transition to insulin and treatment intensification can delay the onset of diabetes complications.

Conclusions:

• The timely and appropriate use of basal insulin is essential for effective T2DM management.
• Addressing physician and patient concerns regarding insulin therapy is critical for adherence.
• A structured approach focusing on the seven vital Ts can improve glycemic control and patient outcomes in T2DM.